Gene: SETX
Official Full Name: senataxinprovided by HGNC
Gene Summary: This gene encodes a protein named for its homology to the Sen1p protein of fungi which has RNA helicase activity encoded by a domain at the C-terminal end of the protein. The protein encoded by this gene contains a DNA/RNA helicase domain at its C-terminal end which suggests that it may be involved in both DNA and RNA processing. Mutations in this gene have been associated with ataxia-ocular apraxia-2 (AOA2) and an autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS4). [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29936 | SETX Knockout cell line (HeLa) | Human | SETX | 1:3~1:6 | Negative | Online Inquiry |
KO29937 | SETX Knockout cell line (HCT 116) | Human | SETX | 1:2~1:4 | Negative | Online Inquiry |
KO29938 | SETX Knockout cell line (HEK293) | Human | SETX | 1:3~1:6 | Negative | Online Inquiry |
KO29939 | SETX Knockout cell line (A549) | Human | SETX | 1:3~1:4 | Negative | Online Inquiry |
SETX Gene Knockout Cell Lines are specialized biological tools designed to help researchers explore the functions and pathways associated with the Senataxin (SETX) gene, known for its role in RNA metabolism and the response to DNA damage. The knockout model is created by using CRISPR-Cas9 technology, which precisely disrupts the SETX gene, allowing for the observation of phenotypic changes resulting from its absence. This method enables researchers to study the genetic, molecular, and cellular implications underlying various diseases, including neurodegenerative disorders, where SETX dysfunction is implicated.
The SETX gene knockout cell lines function by allowing scientists to examine the downstream effects on RNA processing and stability, providing insights into the cellular mechanisms that either promote or inhibit disease progression. By evaluating these knockout cells, researchers can pinpoint critical pathways and potential therapeutic targets for conditions such as amyotrophic lateral sclerosis (ALS) and ataxia.
Scientifically, these cell lines are invaluable as they represent a vital advancement in understanding the biological roles of SETX, shedding light on its contribution to neurological health. Compared to alternative models, such as traditional wild-type cell lines, SETX knockout cell lines provide a clear advantage by enabling targeted studies of gene function in a controlled environment, ensuring high specificity in results.
For researchers and clinicians alike, the ability to utilize SETX gene knockout cell lines enhances the exploration of innovative treatments and accelerates drug development by identifying potential markers for patient stratification and targeting. Moreover, the robustness of these knockout cell lines makes them ideal for high-throughput screening applications.
Our company, with years of expertise in developing cutting-edge genetic tools, is proud to offer these SETX gene knockout cell lines as part of our comprehensive product portfolio. By providing quality biological resources, we empower scientists to unlock the complexities of gene function and drive forward the future of medical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.